Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Makris

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Seminars in Thrombosis and Hemostasis|June 3, 2016
Prophylaxis in von Willebrand Disease: Coming of Age?Giorgia Saccullo, Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2019
Publishing in HaemophiliaMike Makris, Craig Kessler
Research and Practice in Thrombosis and Haemostasis|March 6, 2024
Hello and goodbye Research and Practice in Thrombosis and HaemostasisMike Makris, Mary Cushman
Thrombosis and Haemostasis|January 12, 2012
Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversalPeter Toth, Mike Makris
Blood Transfusion = Trasfusione Del Sangue|November 2, 2012
Non-O blood group: an important genetic risk factor for venous thromboembolismMassimo Franchini, Mike Makris
British Journal of Haematology|July 11, 2012
Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement productsCarolyn M Millar, Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 20, 2013
A new era for the Haemophilia journalMike Makris, Craig Kessler, Samantha Gough
Seminars in Thrombosis and Hemostasis|June 5, 2018
Inherited Thrombophilia and Pregnancy Complications: Should We Test?Deepa R J Arachchillage, Mike Makris
Blood Transfusion = Trasfusione Del Sangue|January 22, 2011
Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?Mike Makris, Joost J Van Veen
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Seminars in Thrombosis and Hemostasis|June 3, 2016
Prophylaxis in von Willebrand Disease: Coming of Age?Giorgia Saccullo, Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2019
Publishing in HaemophiliaMike Makris, Craig Kessler
Research and Practice in Thrombosis and Haemostasis|March 6, 2024
Hello and goodbye Research and Practice in Thrombosis and HaemostasisMike Makris, Mary Cushman
Thrombosis and Haemostasis|January 12, 2012
Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversalPeter Toth, Mike Makris
Blood Transfusion = Trasfusione Del Sangue|November 2, 2012
Non-O blood group: an important genetic risk factor for venous thromboembolismMassimo Franchini, Mike Makris
British Journal of Haematology|July 11, 2012
Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement productsCarolyn M Millar, Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 20, 2013
A new era for the Haemophilia journalMike Makris, Craig Kessler, Samantha Gough
Seminars in Thrombosis and Hemostasis|June 5, 2018
Inherited Thrombophilia and Pregnancy Complications: Should We Test?Deepa R J Arachchillage, Mike Makris
Blood Transfusion = Trasfusione Del Sangue|January 22, 2011
Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?Mike Makris, Joost J Van Veen
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Pageof 9